The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment.

Glycemic profile A marginally significant reduction in FBS levels in patients with NAFLD was observed following probiotic supplementation, with an MD of −4.98 (95% [CI]: [−9.94, −0.01], P =0.04, I 2 =10.8%).

also in 26,082 other papers

Similarly, the effect of probiotics on CRP levels in the NAFLD population did not reach statistical significance, with an MD of −0.41 (95% CI: [−1.84, 1.02], P =0.57, I 2 =46.8%).

also in 111,027 other papers